GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abbott India Ltd (BOM:500488) » Definitions » Cyclically Adjusted PS Ratio

Abbott India (BOM:500488) Cyclically Adjusted PS Ratio : 11.37 (As of Jun. 01, 2024)


View and export this data going back to 1992. Start your Free Trial

What is Abbott India Cyclically Adjusted PS Ratio?

As of today (2024-06-01), Abbott India's current share price is ₹25875.95. Abbott India's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ₹2,276.66. Abbott India's Cyclically Adjusted PS Ratio for today is 11.37.

The historical rank and industry rank for Abbott India's Cyclically Adjusted PS Ratio or its related term are showing as below:

BOM:500488' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 8.63   Med: 10.37   Max: 13.16
Current: 11.37

During the past years, Abbott India's highest Cyclically Adjusted PS Ratio was 13.16. The lowest was 8.63. And the median was 10.37.

BOM:500488's Cyclically Adjusted PS Ratio is ranked worse than
94.62% of 744 companies
in the Drug Manufacturers industry
Industry Median: 2.085 vs BOM:500488: 11.37

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Abbott India's adjusted revenue per share data for the three months ended in Mar. 2024 was ₹677.002. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₹2,276.66 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Abbott India Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Abbott India's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott India Cyclically Adjusted PS Ratio Chart

Abbott India Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.04 8.96 9.67 10.75 11.84

Abbott India Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.75 10.96 10.58 10.19 11.84

Competitive Comparison of Abbott India's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - General subindustry, Abbott India's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott India's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abbott India's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Abbott India's Cyclically Adjusted PS Ratio falls into.



Abbott India Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Abbott India's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=25875.95/2276.66
=11.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott India's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Abbott India's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=677.002/153.0345*153.0345
=677.002

Current CPI (Mar. 2024) = 153.0345.

Abbott India Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 243.286 94.103 395.644
201409 271.765 96.780 429.730
201412 264.627 96.780 418.443
201503 272.618 97.163 429.382
201506 295.733 99.841 453.296
201509 300.028 101.753 451.235
201512 308.176 102.901 458.320
201603 321.802 102.518 480.371
201606 343.193 105.961 495.657
201609 339.314 105.961 490.055
201612 351.280 105.196 511.027
201703 332.028 105.196 483.020
201706 328.387 107.109 469.192
201709 438.149 109.021 615.034
201712 414.819 109.404 580.250
201803 371.028 109.786 517.187
201806 397.647 111.317 546.673
201809 461.045 115.142 612.773
201812 445.932 115.142 592.686
201903 425.136 118.202 550.417
201906 470.066 120.880 595.106
201909 496.376 123.175 616.705
201912 507.388 126.235 615.104
202003 451.535 124.705 554.111
202006 500.833 127.000 603.500
202009 496.400 130.118 583.827
202012 515.468 130.889 602.681
202103 514.448 131.771 597.465
202106 573.070 134.084 654.063
202109 575.087 135.847 647.848
202112 576.169 138.161 638.197
202203 586.459 138.822 646.501
202206 613.704 142.347 659.779
202209 649.096 144.661 686.668
202212 622.236 145.763 653.278
202303 632.008 146.865 658.559
202306 695.967 150.280 708.723
202309 703.158 151.492 710.318
202312 676.269 152.924 676.756
202403 677.002 153.035 677.002

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Abbott India  (BOM:500488) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Abbott India Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Abbott India's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbott India (BOM:500488) Business Description

Traded in Other Exchanges
Address
15-16th Floor, Godrej BKC, Plot C-68, G Block, Near MCA Club, Bandra-Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051
Abbott India Ltd is a major drug manufacturing company that offers products offerings in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals. The vast majority of the company's revenue is generated in the India. The company's patient focus centers overwhelmingly toward women's health and gastrointestine, gastroenterology, and hepatic care. The company expects an increased use of collaboration with strategic partners as a component of its growth strategy.

Abbott India (BOM:500488) Headlines

No Headlines